Barings’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-12,887
| Closed | -$3.66M | – | 442 |
|
|
2020
Q3 | $3.66M | Sell |
12,887
-3,428
| -21% | -$956K | 0.08% | 169 |
|
|
2020
Q2 | $5.16M | Hold |
16,315
| – | – | 0.17% | 111 |
|
|
2020
Q1 | $5.16M | Sell |
16,315
-169
| -1% | -$51.3K | 0.17% | 111 |
|
|
2019
Q4 | $4.89M | Buy |
16,484
+2,994
| +22% | +$831K | 0.13% | 141 |
|
|
2019
Q3 | $3.14M | Sell |
13,490
-1,554
| -10% | -$362K | 0.07% | 199 |
|
|
2019
Q2 | $3.52M | Sell |
15,044
-3,121
| -17% | -$721K | 0.08% | 196 |
|
|
2019
Q1 | $4.29M | Buy |
18,165
+310
| +2% | +$97.6K | 0.1% | 170 |
|
|
2018
Q4 | $5.37M | Sell |
17,855
-310
| -2% | -$98.9K | 0.09% | 130 |
|
|
2018
Q3 | $6.42M | Buy |
18,165
+4,660
| +35% | +$1.6M | 0.09% | 150 |
|
|
2018
Q2 | $3.92M | Buy |
13,505
+2,849
| +27% | +$801K | 0.06% | 216 |
|
|
2018
Q1 | $2.92M | Hold |
10,656
| – | – | 0.04% | 289 |
|
|
2017
Q4 | $3.4M | Hold |
10,656
| – | – | 0.04% | 264 |
|
|
2017
Q3 | $3.34M | Buy |
10,656
+1,000
| +10% | +$296K | 0.06% | 204 |
|
|
2017
Q2 | $2.62M | Sell |
9,656
-5,480
| -36% | -$1.45M | 0.08% | 242 |
|
|
2017
Q1 | $4.14M | Hold |
15,136
| – | – | 0.08% | 179 |
|
|
2016
Q4 | $4.29M | Buy |
15,136
+4,380
| +41% | +$1.3M | 0.11% | 117 |
|
|
2016
Q3 | $3.37M | Sell |
10,756
-3,000
| -22% | -$889K | 0.09% | 147 |
|
|
2016
Q2 | $3.33M | Buy |
13,756
+680
| +5% | +$179K | 0.09% | 161 |
|
|
2016
Q1 | $3.4M | Sell |
13,076
-5,750
| -31% | -$1.52M | 0.09% | 154 |
|
|
2015
Q4 | $5.77M | Buy |
+18,826
| New | +$5.41M | 0.14% | 90 |
|
|
2015
Q3 | – | Sell |
-7,776
| Closed | -$3.14M | – | 904 |
|
|
2015
Q2 | $3.14M | Buy |
7,776
+50
| +0.6% | +$20.1K | 0.1% | 216 |
|
|
2015
Q1 | $3.26M | Sell |
7,726
-10,450
| -57% | -$4.12M | 0.07% | 209 |
|
|
2014
Q4 | $6.17M | Sell |
18,176
-580
| -3% | -$188K | 0.14% | 110 |
|
|
2014
Q3 | $6.21M | Buy |
18,756
+13,010
| +226% | +$4.29M | 0.13% | 111 |
|
|
2014
Q2 | $1.81M | Sell |
5,746
-3,350
| -37% | -$1.01M | 0.05% | 342 |
|
|
2014
Q1 | $2.78M | Buy |
9,096
+5,360
| +143% | +$1.7M | 0.09% | 219 |
|
|
2013
Q4 | $1.04M | Sell |
3,736
-4,160
| -53% | -$1.08M | 0.04% | 408 |
|
|
2013
Q3 | $1.9M | Sell |
7,896
-3,930
| -33% | -$880K | 0.08% | 284 |
|
|
2013
Q2 | $2.54M | Buy |
+11,826
| New | +$2.53M | 0.11% | 186 |
|
Other funds holding BIIB
Barings's BIIB Position: Q4 2020 in Review
Barings sold out of Biogen (BIIB) in Q4 2020, closing a stake of 12,887 shares — an estimated $3.66M sold.
Barings first reported a position in BIIB in Q2 2013 and held it in 29 quarters. The position peaked at $6.42M in Q3 2018. 1,062 funds tracked by Wall St. Rank hold BIIB as of Q4 2020.
- Barings reported no remaining Biogen position as of Q4 2020 after selling out during the quarter.
- Barings sold 12,887 Biogen shares in Q4 2020, an estimated $3.66M.
- Barings first reported a position in Biogen in Q2 2013 and held it in 29 quarters.
- Barings's Biogen position peaked at $6.42M in Q3 2018.
- 1,062 funds tracked by Wall St. Rank held Biogen as of Q4 2020.
Based on Barings's 13F filing for Q4 2020, filed 16 Feb 2021.